Epiallopregnanolone in the treatment of cns disorders

Details Epiallopregnanolone in the treatment of cns disorders Epiallopregnanolone in the treatment of cns disorders

A - Human Necessities

61

K

A61K 31/57 (2006.01) A61P 5/00 (2006.01) A61P 15/18 (2006.01) A61P 25/00 (2006.01)

Patent

CA 2321728

The use of epiallopregnanolone (3.beta.-hydroxy-5.alpha.-pregnan-20-one) for the treatment of inter alia steroid induced mood disorders and CNS disorders is disclosed. Further, the use of epiallopregnanolone for the manufacture of pharmaceuticals is disclosed, together with a list of symptoms suitable for treatment with epiallopregnanolone or pharmaceuticals comprising the same.

La présente invention concerne l'utilisation d'épiallopregnanolone (3 beta -hydroxy-5 alpha -pregnan-20-one) dans le traitement entre autres des troubles de l'humeur d'origine stéroïdienne et des troubles du système nerveux central; ainsi que l'utilisation d'épiallopregnanolone pour fabriquer des médicaments, et qu'une liste de symptômes pouvant être traités avec de l'épiallopregnanolone ou avec des médicaments contenant cette substance.

Affiliated with

Also associated with

Rating

Epiallopregnanolone in the treatment of cns disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Epiallopregnanolone in the treatment of cns disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Epiallopregnanolone in the treatment of cns disorders will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1538649